0.39 USD
▲+0.03+4.03%
盘后 0.38 +2.05%
2026-08-03
市值
$11.99M
市盈率
—
EPS
-1.86
股息率
—
52 周区间
0.34 – 2.88
成交量
156.74K
Beta
2.05
目标价
13.00
52W 低 0.3452W 高 2.88
价格走势
公司简介
Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company’s lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need. It offers SENTI-202, a logic gated off-the-shelf CAR-NK cell therapy for the treatment of blood cancers and relapsed...